고양이 백신 시장 : 시장 규모, 점유율, 동향, 성장 분석(2026-2034년)

The global cat vaccine market size is expected to reach USD 5.01 Billion in 2034 from USD 2.21 Billion in 2025, growing at a CAGR of 9.53 during 2026-2034.This market is experiencing significant growth due to increasing awareness regarding pet healthcare and the rising adoption of companion animals worldwide. Cat vaccines play a critical role in preventing infectious diseases and improving animal health and longevity. Growing expenditure on veterinary care, increasing pet ownership, and rising concern for animal welfare are significantly driving market expansion. Veterinary clinics, animal hospitals, and pet owners are increasingly prioritizing preventive healthcare measures, contributing to higher demand for vaccination products globally.

The increasing prevalence of infectious feline diseases and advancements in veterinary medicine are major factors supporting market growth. Pharmaceutical companies are investing in the development of advanced vaccines that provide broader protection and improved safety profiles. Government regulations promoting animal health management and vaccination programs are also encouraging wider vaccine adoption. In addition, rising awareness regarding zoonotic diseases and preventive pet healthcare is creating substantial opportunities for veterinary pharmaceutical manufacturers across developed and developing regions.

Future prospects for the cat vaccine market remain highly favorable due to continuous advancements in veterinary biotechnology and growing pet humanization trends. Companies are expected to focus on innovative vaccine formulations, combination vaccines, and improved delivery systems to enhance treatment effectiveness and convenience. The expansion of pet insurance coverage and digital veterinary healthcare platforms is likely to further support market growth. Emerging economies are also anticipated to witness increased demand as pet ownership rates and veterinary healthcare infrastructure continue to expand.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Vaccine Type

• Modified/Attenuated Live
• Inactivated (Killed)
• Others

By Disease Type

• Feline Leukemia
• Feline Panleukopenia (Feline Distemper)
• Feline Respiratory Diseases
• Feline Rabies
• Other Diseases

By Route of Administration

• Injectables
• Intranasal
• Oral

By Duration of Immunity

• 1 Year
• 3 Year
• Others

By Component

• Combined Vaccines
• Mono Vaccines

COMPANIES PROFILED

• Virbac, C.H. Boehringer Sohn AG & Co. KG., Elanco, Zoetis, Merck & Co., Bioveta a.s., Indian Immunologicals Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CAT VACCINE MARKET: BY VACCINE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Vaccine Type
• 4.2. Modified/Attenuated Live Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Inactivated (Killed) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CAT VACCINE MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Type
• 5.2. Feline Leukemia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Feline Panleukopenia (Feline Distemper) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Feline Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Feline Rabies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CAT VACCINE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Injectables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Intranasal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CAT VACCINE MARKET: BY DURATION OF IMMUNITY 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Duration Of Immunity
• 7.2. 1 Year Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. 3 Year Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CAT VACCINE MARKET: BY COMPONENT 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Component
• 8.2. Combined Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Mono Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL CAT VACCINE MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Vaccine Type
  • 9.2.2 By Disease Type
  • 9.2.3 By Route Of Administration
  • 9.2.4 By Duration Of Immunity
  • 9.2.5 By Component
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Vaccine Type
  • 9.3.2 By Disease Type
  • 9.3.3 By Route Of Administration
  • 9.3.4 By Duration Of Immunity
  • 9.3.5 By Component
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Vaccine Type
  • 9.4.2 By Disease Type
  • 9.4.3 By Route Of Administration
  • 9.4.4 By Duration Of Immunity
  • 9.4.5 By Component
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Vaccine Type
  • 9.5.2 By Disease Type
  • 9.5.3 By Route Of Administration
  • 9.5.4 By Duration Of Immunity
  • 9.5.5 By Component
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Vaccine Type
  • 9.6.2 By Disease Type
  • 9.6.3 By Route Of Administration
  • 9.6.4 By Duration Of Immunity
  • 9.6.5 By Component
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL CAT VACCINE INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Virbac
  • 11.2.2 C.H. Boehringer Sohn AG & Co. KG
  • 11.2.3 Elanco
  • 11.2.4 Zoetis
  • 11.2.5 Merck & Co
  • 11.2.6 Bioveta A.s
  • 11.2.7 Indian Immunologicals Ltd